ReNerve receives approval in Malaysia
Filed with ASX · · 3 pages · English
ReNerve Limited (ASX, "ReNerve" or "the Company"), a leading Australian medical device innovator focused on solutions for peripheral nerve injury (PNI), is pleased to announce that its NervAlign® Nerve Cuff has received market registration (approval) in Malaysia. "Our approval in Malaysia is part of our regional strategy and is another major piece of validation, showing the strong clinical data pa
Earlier from Renerve
- Broader approval received in Hong Kong for Nerve Cuff
- ReNerve AGM Presentation
- ReNerve completes $3.2m capital raising
- Trading Halt
- Nerve Cuff approved for use in US DoD and VA hospitals
Later from Renerve
- Q2 FY26 Activities Report and Appendix 4C
- 1HFY26 Appendix 4D and Half Year Report
- 1HFY26 Results Announcement
- Nerve Guide Matrix Enters Stage 3 of Commercial Development
- Q3 FY26 Activities Report and Appendix 4C
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve